← ANALYST RATINGS · TIPRANKS
Cardinal Health (CAH): analyst forecast and price target
Analyst consensus
Strong Buy12 Buy2 Hold0 Sell
Ratings of 14 analysts in the last 3 months12-month forecast
Based on 14 price targets given in the last 3 months, the average target is $272, the highest $295, the lowest $250. The average is +6.9% from the last price of $254.
Analyst ratings 21
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI DeepSeek Medical - DistributionDeepSeek R1-0528 | TipRanks - DeepSeek | $270 → $271+0.4% | Hold | +6.7% | Downgrade | 17.10.26on TipRanks 13:05 | — | |
| AI xAi Medical - DistributionxAI Grok-3 | TipRanks - xAI | $243 → $277+14.0% | Hold | +9.0% | Downgrade | 16.10.26on TipRanks 08:05 | — | |
| AI DeepSeek Medical - DistributionDeepSeek R1-0528 | TipRanks - DeepSeek | $237 → $270+13.9% | Hold | +6.3% | Downgrade | 16.10.26on TipRanks 08:05 | — | |
| AI OpenAI Medical - DistributionOpenAI 4o | TipRanks - OpenAI | $236 → $269+14.0% | Hold | +5.9% | Reiterated | 16.10.26on TipRanks 08:05 | — | |
| AI Anthropic Medical - DistributionAnthropic Opus-4.1 | TipRanks - Anthropic | $231 → $264+14.3% | Hold | +3.9% | Reiterated | 16.10.26on TipRanks 08:05 | — | |
| AI Google Medical - DistributionGemini 2.5Pro | TipRanks - Google | $243 → $277+14.0% | Hold | +9.0% | Downgrade | 16.10.26on TipRanks 08:05 | — | |
| AI PerPlexity Medical - DistributionPerPlexity SonarPro | TipRanks - PerPlexity | $244 → $278+13.9% | Hold | +9.4% | Reiterated | 16.10.26on TipRanks 08:05 | — | |
| Kevin Caliendo★★★★★★★★★★#2646 · hits 56% · avg +5.6% | UBS | $280 → $295+5.4% | Buy | +16.1% | Reiterated | 16.10.26on TipRanks 07:55 | +1.2% | ↗ |
| Ryan Halsted★★★★★★★★★★#3317 · hits 60% · avg +9.0% | RBC Capital | $276 | Buy | +8.6% | Reiterated | 12.10.26on TipRanks Oct 13 07:09 | +0.3%next day +0.7% | ↗ |
| Ryan Halsted★★★★★★★★★★#3317 · hits 60% · avg +9.0% | RBC Capital | $276 | Buy | +8.6% | Reiterated | 06.10.26on TipRanks 21:45 | −0.3%next day +3.4% · 5 days +7.7% | ↗ |
| AI xAi Medical - DistributionxAI Grok-3 | TipRanks - xAI | $262 → $243−7.3% | Hold | −4.4% | Downgrade | 01.10.26on TipRanks 16:05 | — | |
| AI DeepSeek Medical - DistributionDeepSeek R1-0528 | TipRanks - DeepSeek | $261 → $237−9.2% | Hold | −6.7% | Downgrade | 01.10.26on TipRanks 16:05 | — | |
| AI OpenAI Medical - DistributionOpenAI 4o | TipRanks - OpenAI | $253 → $236−6.7% | Hold | −7.1% | Reiterated | 01.10.26on TipRanks 16:05 | — | |
| AI Anthropic Medical - DistributionAnthropic Opus-4.1 | TipRanks - Anthropic | $245 → $231−5.7% | Hold | −9.1% | Reiterated | 01.10.26on TipRanks 16:05 | — | |
| AI Google Medical - DistributionGemini 2.5Pro | TipRanks - Google | $265 → $243−8.3% | Hold | −4.4% | Downgrade | 01.10.26on TipRanks 16:05 | — | |
| AI PerPlexity Medical - DistributionPerPlexity SonarPro | TipRanks - PerPlexity | $257 → $244−5.1% | Hold | −4.0% | Reiterated | 01.10.26on TipRanks 16:05 | — | |
| Stephen Baxter★★★★★★★★★★#3289 · hits 50% · avg +3.9% | Wells Fargo | $277 | Buy | +9.0% | Reiterated | 09.09.26on TipRanks Sep 10 05:31 | +0.3%next day −1.1% · 5 days −2.0% | ↗ |
| Ryan Halsted★★★★★★★★★★#3317 · hits 60% · avg +9.0% | RBC Capital | $276 | Buy | +8.6% | Initiated | 19.08.26on TipRanks 04:40 | −0.3%next day −1.9% · 5 days +1.9% | ↗ |
| AI PerPlexity Medical - DistributionPerPlexity SonarPro | TipRanks - PerPlexity | $263 → $257−2.3% | Hold | +1.2% | Reiterated | 19.08.26on TipRanks Aug 18 23:05 | — | |
| Glen Santangelo★★★★★★★★★★#2956 · hits 52% · avg +4.5% | Barclays | $275 | Buy | +8.2% | Reiterated | 18.08.26on TipRanks Aug 19 03:11 | +0.4%next day −0.3% · 5 days +1.5% | ↗ |
| Lisa Gill★★★★★★★★★★#1237 · hits 58% · avg +9.0% | J.P. Morgan | $260 | Hold | +2.3% | Reiterated | 17.08.26on TipRanks 08:07 | +0.7%next day +0.4% · 5 days −0.2% | ↗ |
| AI Google Medical - DistributionGemini 2.5Pro | TipRanks - Google | $262 → $265+1.1% | Buy | +4.3% | Reiterated | 17.08.26on TipRanks 05:05 | — | |
| AI xAi Medical - DistributionxAI Grok-3 | TipRanks - xAI | $252 → $262+4.0% | Buy | +3.1% | Upgrade | 17.08.26on TipRanks 05:05 | — | |
| AI Anthropic Medical - DistributionAnthropic Opus-4.1 | TipRanks - Anthropic | $241 → $245+1.7% | Hold | −3.6% | Reiterated | 17.08.26on TipRanks 05:05 | — | |
| AI DeepSeek Medical - DistributionDeepSeek R1-0528 | TipRanks - DeepSeek | $249 → $261+4.8% | Buy | +2.7% | Upgrade | 17.08.26on TipRanks 05:05 | — | |
| AI OpenAI Medical - DistributionOpenAI 4o | TipRanks - OpenAI | $251 → $253+0.8% | Hold | −0.4% | Reiterated | 17.08.26on TipRanks 05:05 | — | |
| George Hill★★★★★★★★★★#1126 · hits 54% · avg +9.0% | Deutsche Bank | $223 → $261+17.0% | Hold | +2.7% | Reiterated | 13.08.26on TipRanks 09:30 | −1.9%next day +1.9% · 5 days +0.8% | ↗ |
| Steven Valiquette★★★★★★★★★★#8240 · hits 53% · avg 0.0% | Mizuho Securities | $240 → $250+4.2% | Buy | −1.6% | Reiterated | 13.08.26on TipRanks 08:15 | −1.9%next day +1.9% · 5 days +0.8% | ↗ |
| Charles Rhyee★★★★★★★★★★#1937 · hits 54% · avg +5.6% | TD Cowen | $275 → $280+1.8% | Buy | +10.2% | Assigned | 13.08.26on TipRanks Aug 12 18:10 | −1.9%next day +1.9% · 5 days +0.8% | ↗ |
| Elizabeth Anderson CFA★★★★★★★★★★#2664 · hits 55% · avg +4.4% | Evercore ISI | $270 | Buy | +6.3% | Reiterated | 12.08.26on TipRanks 09:45 | −2.8%next day −1.9% · 5 days +0.7% | ↗ |
| Erin Wright★★★★★★★★★★#354 · hits 64% · avg +15.1% | Morgan Stanley | $265 → $255−3.8% | Buy | +0.4% | Reiterated | 12.08.26on TipRanks 08:20 | −2.8%next day −1.9% · 5 days +0.7% | ↗ |
| Daniel Grosslight★★★★★★★★★★#4007 · hits 47% · avg +3.6% | Citi | $265 → $280+5.7% | Buy | +10.2% | Reiterated | 12.08.26on TipRanks 06:55 | −2.8%next day −1.9% · 5 days +0.7% | ↗ |
| Michael Cherny★★★★★★★★★★#2074 · hits 57% · avg +5.7% | Leerink Partners | $275 → $292+6.2% | Buy | +14.9% | Reiterated | 11.08.26on TipRanks 15:05 | +1.6%next day −2.8% · 5 days −1.8% | ↗ |
| Ryan Daniels★★★★★★★★★★#2878 · hits 48% · avg +5.8% | William Blair | — | Buy | — | Reiterated | 11.08.26on TipRanks 10:37 | +1.6%next day −2.8% · 5 days −1.8% | ↗ |
| Allen Lutz★★★★★★★★★★#598 · hits 67% · avg +12.3% | Bank of America Securities | $260 | Buy | +2.3% | Reiterated | 20.07.26on TipRanks Jul 24 05:14 | −1.1%next day −0.2% · 5 days +2.0% | ↗ |
| Kevin Caliendo★★★★★★★★★★#2646 · hits 56% · avg +5.6% | UBS | $260 → $274+5.4% | Buy | +7.8% | Assigned | 20.07.26on TipRanks Jul 24 05:14 | −1.1%next day −0.2% · 5 days +2.0% | ↗ |
| Unknown Analyst | William O'Neil | — | Buy | — | Initiated | 12.06.26on TipRanks Jun 15 23:05 | +0.7%next day −0.6% · 5 days −1.1% | ↗ |
| Steven Silver★★★★★★★★★★#2962 · hits 80% · avg +22.7% | Argus Research | $248 | Buy | −2.4% | Reiterated | 05.05.26on TipRanks May 11 11:15 | −0.8%next day −4.2% · 5 days −9.3% | ↗ |
| Eric Coldwell★★★★★★★★★★#1091 · hits 59% · avg +7.7% | Robert W. Baird | $257 → $248−3.5% | Buy | −2.4% | Reiterated | 01.05.26on TipRanks 08:55 | +0.9%next day +1.3% · 5 days −8.3% | ↗ |
| Brian Tanquilut★★★★★★★★★★#1681 · hits 52% · avg +6.6% | Jefferies | $220 → $270+22.7% | Buy | +6.3% | Reiterated | 22.01.26on TipRanks 06:01 | −1.3%next day +0.7% · 5 days +1.4% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Cardinal Health
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $270 at a price of $222 (+21.3%); now: $272 at $254 (+6.9%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 13 | 14 | 16 | 20 | 19 | 15 |
| Hold | 1 | 1 | 1 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 05.11.26 (Q1 2027, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $2.95 (from $2.88 to $3.09). Last quarter: $2.91.
Sales
Next quarter’s sales estimate — $66.6B (from $65.1B to $67.3B). Last quarter: $63.7B.
Best top-analyst consensus in the sector · Healthcare
About Cardinal Health
- CEO: Jason Hollar
- Employees: 61,344
- 7000 Cardinal Place, Dublin, OH, 43017, US
- www.cardinalhealth.com
Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare
Data from the stock’s TipRanks forecast page, read 4 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗